284 results
Page 2 of 15
424B5
j3u13if5 on1
31 May 23
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.1
kx7ddxl28ybb
2 May 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
6p1f1z
27 Apr 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
k85ifmvf ilt3j
9 Nov 22
Lexicon Pharmaceuticals Reports Third Quarter 2022
4:05pm
8-K
EX-99.1
941 6j1wq8zdmhxjosch
2 Aug 22
Lexicon Pharmaceuticals Reports Second Quarter 2022
4:07pm
8-K
EX-1.1
kjlkb2 plf
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
424B5
62mpk fis
29 Jul 22
Prospectus supplement for primary offering
8:12am
424B5
rjmz 9s5yy67f
27 Jul 22
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.1
b6dobu0sy2v3n
30 Jun 22
Lexicon Announces Positive Top-line Results from Phase 2 Proof-of-concept Study of LX9211 In Painful Diabetic Neuropathy
12:52pm
8-K
EX-3.1
5v41lhljz 5w5aez
25 May 22
Material Modifications to Rights of Security Holders
8:27am